FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309194054> ?p ?o ?g. }

• W4309194054 endingPage "C013" @default.
• W4309194054 startingPage "C013" @default.
• W4309194054 abstract "Abstract Findings from the recently reported phase 2 PRINCE trial for patients with metastatic pancreatic cancer suggest potential clinical benefit with certain combinations of chemotherapy and immunotherapy. Overall survival following gemcitabine/nab-paclitaxel and either PD-1 blocking antibody or CD40 agonistic antibody (aCD40) correlated with the prevalence of distinct T cell subsets in circulation at baseline and with the extent of certain tumor infiltrating T cells (Padron et al., Nature Medicine, 2022). Here, we modeled the therapeutic effect of aCD40/PD-1/CTLA-4 therapy in the absence of chemotherapy in mice bearing tumors derived from the autochthonous pancreatic ductal adenocarcinoma (PDAC) KPC model and studied the dependency of tumor regression on the degree of tumor infiltrating T cells. We used a panel of KPC tumor cell clones that exhibit reproducible and transplantable levels of T cell infiltration ranging between high, intermediate, and low amounts. Mice were subcutaneously injected with clonal PDAC lines and treated 14-21 days later with either aCD40 alone or aCD40/PD-1/CTLA-4 (all i.p., n=5-8 mice per cohort of T cell high, intermediate and low clones). Systemic immune dynamics were surveyed by bleeding mice on day 0, 7, and 14 of treatment and analyzing for immune cell activation and exhaustion markers. In mice bearing T cell high and intermediate tumors, aCD40/PD-1/CTLA-4 induced higher rates of complete tumor regressions (71% for T cell high; 25% for T cell intermediate) and prolonged survival (P &lt; 0.001 for T cell high; P = 0.013 for T cell intermediate) compared to untreated controls. Treatment with aCD40 alone was effective in mice with T cell intermediate tumors, leading to regressions in 29% of mice. In mice bearing T cell low tumors, however, tumor regressions after aCD40/PD-1/CTLA-4 were less frequent (12.5%), although survival was improved significantly following the treatment (P &lt;0.001). aCD40 alone improved overall survival of T cell low bearing mice (P = 0.026) without inducing tumor regressions. Regardless of T cell high, intermediate, or low tumors, aCD40/PD-1/CTLA-4 increased the proportions of circulating activated and exhausted CD4+ and CD8+ T cells. aCD40/PD-1/CTLA-4 also increased T cell infiltration into T cell low tumors, but this enhanced infiltration did not correlate with complete regressions. Thus, using tumor clones derived from the same autochthonous genetic model, we show that response to combination immunotherapy is a function of baseline T cell content, with ‘hot’ tumors responding the best and ‘cold’ tumors responding the worst. Additional tumor cell-intrinsic factors such as those revealed in other mouse experiments and in the human samples from the PRINCE study likely restrict a robust anti-tumor immune response even when T cells have been recruited. Citation Format: Noah C. Cheng, Nune Markosyan, Robert H. Vonderheide. Response to combination immunotherapy in a mouse model of PDAC is a function of baseline T cell content [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer; 2022 Sep 13-16; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2022;82(22 Suppl):Abstract nr C013." @default.
• W4309194054 created "2022-11-24" @default.
• W4309194054 creator A5011422198 @default.
• W4309194054 creator A5040750947 @default.
• W4309194054 creator A5071804321 @default.
• W4309194054 date "2022-11-15" @default.
• W4309194054 modified "2023-09-25" @default.
• W4309194054 title "Abstract C013: Response to combination immunotherapy in a mouse model of PDAC is a function of baseline T cell content" @default.
• W4309194054 doi "https://doi.org/10.1158/1538-7445.panca22-c013" @default.
• W4309194054 hasPublicationYear "2022" @default.
• W4309194054 type Work @default.
• W4309194054 citedByCount "0" @default.
• W4309194054 crossrefType "journal-article" @default.
• W4309194054 hasAuthorship W4309194054A5011422198 @default.
• W4309194054 hasAuthorship W4309194054A5040750947 @default.
• W4309194054 hasAuthorship W4309194054A5071804321 @default.
• W4309194054 hasConcept C121608353 @default.
• W4309194054 hasConcept C126322002 @default.
• W4309194054 hasConcept C143998085 @default.
• W4309194054 hasConcept C159654299 @default.
• W4309194054 hasConcept C203014093 @default.
• W4309194054 hasConcept C2776090121 @default.
• W4309194054 hasConcept C2776694085 @default.
• W4309194054 hasConcept C2777701055 @default.
• W4309194054 hasConcept C2780210213 @default.
• W4309194054 hasConcept C2780258809 @default.
• W4309194054 hasConcept C502942594 @default.
• W4309194054 hasConcept C71924100 @default.
• W4309194054 hasConcept C8891405 @default.
• W4309194054 hasConceptScore W4309194054C121608353 @default.
• W4309194054 hasConceptScore W4309194054C126322002 @default.
• W4309194054 hasConceptScore W4309194054C143998085 @default.
• W4309194054 hasConceptScore W4309194054C159654299 @default.
• W4309194054 hasConceptScore W4309194054C203014093 @default.
• W4309194054 hasConceptScore W4309194054C2776090121 @default.
• W4309194054 hasConceptScore W4309194054C2776694085 @default.
• W4309194054 hasConceptScore W4309194054C2777701055 @default.
• W4309194054 hasConceptScore W4309194054C2780210213 @default.
• W4309194054 hasConceptScore W4309194054C2780258809 @default.
• W4309194054 hasConceptScore W4309194054C502942594 @default.
• W4309194054 hasConceptScore W4309194054C71924100 @default.
• W4309194054 hasConceptScore W4309194054C8891405 @default.
• W4309194054 hasIssue "22_Supplement" @default.
• W4309194054 hasLocation W43091940541 @default.
• W4309194054 hasOpenAccess W4309194054 @default.
• W4309194054 hasPrimaryLocation W43091940541 @default.
• W4309194054 hasRelatedWork W1969578744 @default.
• W4309194054 hasRelatedWork W2005537476 @default.
• W4309194054 hasRelatedWork W2319496893 @default.
• W4309194054 hasRelatedWork W2349340765 @default.
• W4309194054 hasRelatedWork W2365966720 @default.
• W4309194054 hasRelatedWork W2370585970 @default.
• W4309194054 hasRelatedWork W2376347278 @default.
• W4309194054 hasRelatedWork W2419408601 @default.
• W4309194054 hasRelatedWork W3196960728 @default.
• W4309194054 hasRelatedWork W4311308018 @default.
• W4309194054 hasVolume "82" @default.
• W4309194054 isParatext "false" @default.
• W4309194054 isRetracted "false" @default.
• W4309194054 workType "article" @default.